Conclusions: Most guidelines recommend weight reduction through physical activity and
improving nutrition, as these have proven positive effects on health outcomes when …

Background Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic
liver disease worldwide. However, there is no clear consensus on optimal screening …

Non-alcoholic fatty liver disease (NAFLD) affects one-third of the world's adult population
and is linked to metabolic syndrome. It can progress to steatohepatitis, cirrhosis and …

Objective Metabolic associated fatty liver disease (MAFLD) affects nearly a quarter of the
world's population. Our study aimed to characterize the gut microbiome and overall changes …

An international panel recently proposed an update to the terminology and diagnostic
criteria for fatty liver disease. The experts proposed a change in the nomenclature from non …

The prevalence of metabolic-associated fatty liver disease (MAFLD) has increased
substantially in recent years because of the global obesity pandemic. MAFLD, now …

Background The prevalence of metabolism-related fatty liver disease (MAFLD) has been
rarely reported in hospital staffs. The aim of this study was to assess the prevalence and risk …

Nonalcoholic fatty liver disease (NAFLD) is now the most prevalent chronic liver disease.
Many hepatic abnormalities are associated with NAFLD such as nonalcoholic …

Non-alcoholic steatohepatitis (NASH) is a subtype of nonalcoholic fatty liver disease and a
progressive and chronic liver disorder with a significant risk for the development of liver …

Background & Aims The liver is a vital organ responsible for numerous metabolic processes,
which can be significantly impacted by long non-coding RNAs (lncRNAs) and microRNAs …